Magnetic Resonance Imaging of Myelin

Neurotherapeutics

Volumn 4, Issue 3, 2007, Pages 460-484

  Laule, Cornelia ^a   Vavasour, Irene M ^a   Kolind, Shannon H ^a   Li, David K B ^a   Traboulsee, Tony L ^a   Moore, G R Wayne ^a   MacKay, Alex L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

diffusion; histologic validation; magnetization transfer; MR; MR spectroscopy; Myelin; T2

Indexed keywords

MYELIN;

ARTICLE; DIFFUSION WEIGHTED IMAGING; HISTOLOGY; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERIPHERAL NERVE; PRIORITY JOURNAL;

ANIMALS; HUMANS; MAGNETIC RESONANCE IMAGING; MYELIN SHEATH;

EID: 34250739339     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2007.05.004     Document Type: Article

References (285)

1. Morell P., Quarles R.H., and Norton W. Formation, structure, and biochemistry of myelin. In: Siegel J. (Ed). Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 4th ed. (1989), Raven Press Ltd, New York 109-136
2. Van De Graff K.M. Nervous tissue and the central nervous system. In: Van De Graff K.M. (Ed). Human Anatomy. 6th ed. (2002), McGraw-Hill, New York 351
3. Trapp B., and Kidd G. Structure of the myelinated axon. In: Lazzarini R. (Ed). Myelin Biology and Disorders 1 (2004), Elsevier Academic Press, London 3-27
4. Taylor C., Marta C., Bansal R., and Pfeiffer S. The transport, assembly, and function of myelin lipids. In: Lazzarini R. (Ed). Myelin Biology and Disorders 1 (2004), Elsevier Academic Press, London 57-88
5. Kirschner D.A., Ganser A.L., and Caspar D.L.D. Diffraction studies of molecular organization and membrane interactions in myelin. In: Morell P. (Ed). Myelin. 2nd ed. (1984), Plenum Press, New York 51-95
6. Edgar J.M., McLaughlin M., Yool D., et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166 (2004) 121-131
7. Bjartmar C., and Trapp B.D. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14 (2001) 271-278
8. Kirkpatrick L.L., Witt A.S., Payne H.R., et al. Changes in microtubule stability and density in myelin-deficient shiverer mouse CNS axons. J Neurosci 21 (2001) 2288-2297
9. Edgar J.M., and Garbern J. The myelinated axon is dependent on the myelinating cell for support and maintenance: molecules involved. J Neurosci Res 76 (2004) 593-598
10. Boucher S.E., Cypher M.A., Carlock L.R., and Skoff R.P. Proteolipid protein gene modulates viability and phenotype of neurons. J Neurosci 22 (2002) 1772-1783
11. Dyer C.A. The structure and function of myelin: from inert membrane to perfusion pump. Neurochem Res 27 (2002) 1279-1292
12. Tsunoda I., and Fujinami R.S. Inside-out versus outside-in models for virus induced demyelination: axonal damage triggering demyelination. Springer Semin Immunopathol 24 (2002) 105-125
13. Mottershead J.P., Schmierer K., Clemence M., et al. High field MRI correlates of myelin content and axonal density in multiple sclerosis-a post-mortem study of the spinal cord. J Neurol 250 (2003) 1293-1301
14. Schmierer K., Scaravilli F., Altmann D.R., et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 56 (2004) 407-415
15. Stewart W.A., MacKay A.L., Whittall K.P., et al. Spin-spin relaxation in experimental allergic encephalomyelitis. Analysis of CPMG data using a non-linear least squares method and linear inverse theory. Magn Reson Med 29 (1993) 767-775
16. Waldman A., Rees J.H., Brock C.S., et al. MRI of the brain with ultra-short echo-time pulse sequences. Neuroradiology 45 (2003) 887-892
17. Kilby P.M., Bolas N.M., and Radda G.K. 31P-NMR study of brain phospholipid structures in vivo. Biochim Biophys Acta 1085 (1991) 257-264
18. Barkovich A.J. Magnetic resonance techniques in the assessment of myelin and myelination. J Inherit Metab Dis 28 (2005) 311-343
19. Fatouros P.P., and Marmarou A. Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. J Neurosurg 90 (1999) 109-115
20. Kamman R.L., Go K.G., Brouwer W., and Berendsen H.J. Nuclear magnetic resonance relaxation in experimental brain edema: effects of water concentration, protein concentration, and temperature. Magn Reson Med 6 (1988) 265-274
21. Beaulieu C. The basis of anisotropic water diffusion in the nervous system-a technical review. NMR Biomed 15 (2002) 435-455
22. Song S.K., Sun S.W., Ju W.K., et al. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20 (2003) 1714-1722
23. Song S.K., Sun S.W., Ramsbottom M.J., et al. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17 (2002) 1429-1436
24. Wolff S.D., and Balaban R.S. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 10 (1989) 135-144
25. Sled J.G., Levesque I., Santos A.C., et al. Regional variations in normal brain shown by quantitative magnetization transfer imaging. Magn Reson Med 51 (2004) 299-303
26. Ropele S., Strasser-Fuchs S., Augustin M., et al. A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 21 (2000) 1885-1891
27. Ropele S., Seifert T., Enzinger C., and Fazekas F. Method for quantitative imaging of the macromolecular 1H fraction in tissues. Magn Reson Med 49 (2003) 864-871
28. Gareau P.J., Rutt B.K., Karlik S.J., and Mitchell J.R. Magnetization transfer and multicomponent T2 relaxation measurements with histopathologic correlation in an experimental model of MS. J Magn Reson Imaging 11 (2000) 586-595
29. MacKay A., Whittall K., Adler J., et al. In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 31 (1994) 673-677
30. Whittall K.P., MacKay A.L., Graeb D.A., et al. In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med 37 (1997) 34-43
31. Poon C.S., and Henkelman R.M. Practical T2 quantitation for clinical applications. J Magn Reson Imaging 2 (1992) 541-553
32. Vavasour I.M., Whittall K.P., Li D.K., and MacKay A.L. Different magnetization transfer effects exhibited by the short and long T(2) components in human brain. Magn Reson Med 44 (2000) 860-866
33. Bjarnason T., Vavasour I., Chia C., and MacKay A. Characterization of the NMR behaviour of white matter in bovine brain. Magn Reson Med 54 (2005) 1072-1081
34. Stanisz G.J., Kecojevic A., Bronskill M.J., and Henkelman R.M. Characterizing white matter with magnetization transfer and T(2). Magn Reson Med 42 (1999) 1128-1136
35. Oh J., Han E.T., Pelletier D., and Nelson S.J. Measurement of in vivo multi-component T2 relaxation times for brain tissue using multi-slice T2 prep at 1.5 and 3 T. Magn Reson Imaging 24 (2006) 33-43
36. Foltz W.D., Al-Kwifi O., Sussman M.S., et al. Optimized spiral imaging for measurement of myocardial T2 relaxation. Magn Reson Med 49 (2003) 1089-1097
37. Mädler B., and MacKay A.L. In-vivo 3D multi-component T2-relaxation measurements for quantitative myelin imaging at 3T (2006) 2112 14th Annual Meeting of the International Society of Magnetic Resonance in Medicine, Seattle
38. Fenrich F.R., Beaulieu C., and Allen P.S. Relaxation times and microstructures. NMR Biomed 14 (2001) 133-139
39. Graham S.J., Stanchev P.L., and Bronskill M.J. Criteria for analysis of multicomponent tissue T2 relaxation data. Magn Reson Med 35 (1996) 370-378
40. Whittall K.P., and MacKay A.L. Quantitative interpretation of NMR relaxation data. J Magn Reson 84 (1989) 64-71
41. Lawson C.L., and Hanson R.J. Solving least squares problems (1974), Prentice-Hall, Englewood Cliffs, NJ 1-311
42. Stanisz G.J., and Henkelman R.M. Diffusional anisotropy of T2 components in bovine optic nerve. Magn Reson Med 40 (1998) 405-410
43. Jones C.K., Xiang Q.S., Whittall K.P., and MacKay A.L. Linear combination of multiecho data: short T2 component selection. Magn Reson Med 51 (2004) 495-502
44. Vidarsson L., Conolly S.M., Lim K.O., et al. Echo time optimization for linear combination myelin imaging. Magn Reson Med 53 (2005) 398-407
45. Does M.D., Beaulieu C., Allen P.S., and Snyder R.E. Multi-component T1 relaxation and magnetization transfer in peripheral nerve. Magn Reson Imaging 16 (1998) 1033-1041
46. Tozer D.J., Davies G.R., Altmann D.R., et al. Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysis. Magn Reson Med 53 (2005) 1415-1422
47. Wu Y., Alexander A.L., Fleming J.O., et al. Myelin water fraction in human cervical spinal cord in vivo. J Comput Assist Tomogr 30 (2006) 304-306
48. Chia C.L.L., Bjarnason T.A., Mackay A.L., and Pike G.B. Cross-site reproducibility of myelin water estimates (2006) 2520 14th Annual Meeting of the International Society of Magnetic Resonance in Medicine, Seattle
49. Oakden W., Lobaugh N.J., Black S.E., and Stanisz G.J. T2 hyperintensity does not always mean demyelination (and neither does decreased fractional anisotropy) (2006) P41 Proceedings from Imaging myelin: formation, destruction and repair. Vancouver, Canada
50. Dula A.N., Does M.D., and Gochberg D.F. Imaging myelin: formation, destruction and repair (2006) P39 Proceedings from Imaging of myelin in ferret brain using magnetic resonance multi-component T2 and qMT. Vancouver, BC
51. Du Y.P., Chu R., Brown M.S., et al. Quantitative multi-slice mapping of the myelin water fraction using multi-compartment analysis of T2* relaxation at 3T (2006) 2104 14th Annual Meeting of the International Society of Magnetic Resonance in Medicine, Seattle
52. Swift T.J., and Fritz Jr. O.G. A proton spin-echo study of the state of water in frog nerves. Biophys J 9 (1969) 54-59
53. Vasilescu V., Katona E., Simplaceanu V., and Demco D. Water compartments in the myelinated nerve. III. Pulsed NMR results. Experientia 34 (1978) 1443-1444
54. Does M.D., and Snyder R.E. T2 relaxation of peripheral nerve measured in vivo. Magn Reson Imaging 13 (1995) 575-580
55. Menon R.S., Rusinko M.S., and Allen P.S. Proton relaxation studies of water compartmentalization in a model neurological system. Magn Reson Med 28 (1992) 264-274
56. Jolesz F.A., Polak J.F., Adams D.F., and Ruenzel P.W. Myelinated and nonmyelinated nerves: comparison of proton MR properties. Radiology 164 (1987) 89-91
57. Kucharczyk W., Macdonald P.M., Stanisz G.J., and Henkelman R.M. Relaxivity and magnetization transfer of white matter lipids at MRI: importance of cerebrosides and pH. Radiology 192 (1994) 521-529
58. Jolesz F.A., Polak J.F., Ruenzel P.W., and Adams D.F. Wallerian degeneration demonstrated by magnetic resonance: spectroscopic measurements on peripheral nerve. Radiology 152 (1984) 85-87
59. Titelbaum D.S., Frazier J.L., Grossman R.I., et al. Wallerian degeneration and inflammation in rat peripheral nerve detected by in vivo MRI. AJNR Am J Neuroradiol 10 (1989) 741-746
60. Does M.D., and Snyder R.E. Multiexponential T2 relaxation in degenerating peripheral nerve. Magn Reson Med 35 (1996) 207-213
61. Webb S., Munro C.A., Midha R., and Stanisz G.J. Is multicomponent T2 a good measure of myelin content in peripheral nerve?. Magn Reson Med 49 (2003) 638-645
62. Wessig C., Bendszus M., and Stoll G. In vivo visualization of focal demyelination in peripheral nerves by gadofluorine M-enhanced magnetic resonance imaging. Exp Neurol 15 (2006) 15
63. Dousset V., Brochet B., Vital A., et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer. AJNR Am J Neuroradiol 16 (1995) 225-231
64. Dousset V., Grossman R.I., Ramer K.N., et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. [erratum appears in Radiology 1992;183:878]. Radiology 182 (1992) 483-491
65. Deloire-Grassin M.S., Brochet B., Quesson B., et al. In vivo evaluation of remyelination in rat brain by magnetization transfer imaging. J Neurol Sci 178 (2000) 10-16
66. McGowan J.C., Berman J.I., Ford J.C., et al. Characterization of experimental spinal cord injury with magnetization transfer ratio histograms. J Magn Reson Imaging 12 (2000) 247-254
67. Brochet B., and Dousset V. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. Neurology 53 (1999) S12-S17
68. Cook L.L., Foster P.J., Mitchell J.R., and Karlik S.J. In vivo 4.0-T magnetic resonance investigation of spinal cord inflammation, demyelination, and axonal damage in chronic-progressive experimental allergic encephalomyelitis. J Magn Reson Imaging 20 (2004) 563-571
69. Blezer E.L., Bauer J., Brok H.P., et al. Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis. NMR Biomed 20 (2007) 90-103
70. Gareau P.J., Rutt B.K., Bowen C.V., et al. In vivo measurements of multi-component T2 relaxation behaviour in guinea pig brain. Magn Reson Imaging 17 (1999) 1319-1325
71. Stanisz G.J., Webb S., Munro C.A., et al. MR properties of excised neural tissue following experimentally induced neuroinflammation. Magn Reson Med 51 (2004) 473-479
72. Yung A., Choo A., Liu J., et al. Measurements of myelin water in rat spinal cord in vivo. [abstract]. Int Soc Magn Reson Med (2004) 1537 Kyoto, Japan
73. Pun T.W., Odrobina E., Xu Q.G., et al. Histological and magnetic resonance analysis of sciatic nerves in the tellurium model of neuropathy. J Peripher Nerv Syst 10 (2005) 38-46
74. Odrobina E.E., Lam T.Y., Pun T., et al. MR properties of excised neural tissue following experimentally induced demyelination. NMR Biomed 18 (2005) 277-284
75. van Waesberghe J.H., Kamphorst W., De Groot C.J., et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 46 (1999) 747-754
76. Bot J.C., Blezer E.L., Kamphorst W., et al. The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MRI findings to histopathologic results. Radiology 233 (2004) 531-540
77. Nagara H., Inoue T., Koga T., et al. Formalin fixed brains are useful for magnetic resonance imaging (MRI) study. J Neurol Sci 81 (1987) 67-77
78. Laule C., Leung E., Li D.K., et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler 12 (2006) 747-753
79. Moore G.R.W., Leung E., MacKay A.L., et al. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology 55 (2000) 1506-1510
80. Klüver H., and Barrera E. A method for the combined staining of cells and fibres in the nervous system. J Neuropathol Exp Neurol 12 (1953) 400-403
81. Segarra J. Histological and Histochemical Staining Methods. In: Teduchi C. (Ed). Neuropathology Methods and Diagnosis (1970), Little, Brown and Company, Boston 233-269
82. Salthouse T. Luxol fast blue ARN: a new solvent azo dye with improved staining qualities for myelin and phospholipids. Stain Technol 37 (1962) 313-316
83. Lycette R., Danforth J., Koppel J., and Olwin J. The binding of luxol fast blur ARN by various biological lipids. Stain Technol 45 (1970) 155-160
84. Teresi L.M., Hovda D., Seeley A.B., et al. MR imaging of experimental demyelination. AJR Am J Roentgenol 152 (1989) 1291-1298
85. van Walderveen M.A., Kamphorst W., Scheltens P., et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 50 (1998) 1282-1288
86. Bitsch A., Kuhlmann T., Stadelmann C., et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 49 (2001) 793-796
87. Bergers E., Bot J.C., De Groot C.J., et al. Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions. Neurology 59 (2002) 1766-1771
88. Lycklama a Nijeholt G.J., Uitdehaag B.M., Bergers E., et al. Spinal cord magnetic resonance imaging in suspected multiple sclerosis. Eur Radiol 10 (2000) 368-376
89. Bo L., Geurts J.J., van der Valk P., et al. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 64 (2007) 76-80
90. Song S.K., Yoshino J., Le T.Q., et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 26 (2005) 132-140
91. Sun S.W., Liang H.F., Le T.Q., et al. Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving optic nerve injury in mice with retinal ischemia. Neuroimage 32 (2006) 1195-1204
92. Sun S.W., Liang H.F., Trinkaus K., et al. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med 55 (2006) 302-308
93. Sun S.W., Neil J.J., and Song S.K. Relative indices of water diffusion anisotropy are equivalent in live and formalin-fixed mouse brains. Magn Reson Med 50 (2003) 743-748
94. Sun S.W., Song S.K., Harms M.P., et al. Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging. Exp Neurol 191 (2005) 77-85
95. Biton I.E., Duncan I.D., and Cohen Y. High b-value q-space diffusion MRI in myelin-deficient rat spinal cords. Magn Reson Imaging 24 (2006) 161-166
96. Ford J.C., Hackney D.B., Alsop D.C., et al. MRI characterization of diffusion coefficients in a rat spinal cord injury model. Magn Reson Med 31 (1994) 488-494
97. Kim J.H., Budde M.D., Liang H.F., et al. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis 21 (2006) 626-632
98. Harsan L.A., Poulet P., Guignard B., et al. Brain dysmyelination and recovery assessment by noninvasive in vivo diffusion tensor magnetic resonance imaging. J Neurosci Res 83 (2006) 392-402
99. Schmierer K., Wheeler-Kingshott C.A., Boulby P.A., et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage 35 (2007) 467-477
100. Yakovlev P., and Lecours A. The myelogenic cycles of regional maturation of the brain. In: Minkowski A. (Ed). Regional Development of the Brain in Early Life (1967), Blackwell, Oxford 3-70
101. Valencia M.P., and Castillo M. MRI findings in posttraumatic spinal cord Wallerian degeneration. Clin Imaging 30 (2006) 431-433
102. Kinney H.C., Brody B.A., Kloman A.S., and Gilles F.H. Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J Neuropathol Exp Neurol 47 (1988) 217-234
103. Matsumae M., Kurita D., Atsumi H., et al. Sequential changes in MR water proton relaxation time detect the process of rat brain myelination during maturation. Mech Ageing Dev 122 (2001) 1281-1291
104. Barkovich A.J., Kjos B.O., Jackson Jr. D.E., and Norman D. Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T. Radiology 166 (1988) 173-180
105. Huppi P.S., Maier S.E., Peled S., et al. Microstructural development of human newborn cerebral white matter assessed in vivo by diffusion tensor magnetic resonance imaging. Pediatr Res 44 (1998) 584-590
106. Morriss M.C., Zimmerman R.A., Bilaniuk L.T., et al. Changes in brain water diffusion during childhood. Neuroradiology 41 (1999) 929-934
107. Klingberg T., Vaidya C.J., Gabrieli J.D., et al. Myelination and organization of the frontal white matter in children: a diffusion tensor MRI study. Neuroreport 10 (1999) 2817-2821
108. van der Knaap M.S., and Valk J. Magnetic resonance of myelin, myelination and myelin disorders (1996), Springer, New York 31-38
109. Prayer D., Barkovich A.J., Kirschner D.A., et al. Visualization of nonstructural changes in early white matter development on diffusion-weighted MR images: evidence supporting premyelination anisotropy. AJNR Am J Neuroradiol 22 (2001) 1572-1576
110. Ashtari M., Cervellione K.L., Hasan K.M., et al. White matter development during late adolescence in healthy males: A cross-sectional diffusion tensor imaging study. Neuroimage 26 (2007) 26
111. Sullivan E.V., and Pfefferbaum A. Diffusion tensor imaging and aging. Neurosci Biobehav Rev 30 (2006) 749-761
112. Ota M., Obata T., Akine Y., et al. Age-related degeneration of corpus callosum measured with diffusion tensor imaging. Neuroimage 31 (2006) 1445-1452
113. Pfefferbaum A., Sullivan E.V., Hedehus M., et al. Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn Reson Med 44 (2000) 259-268
114. Salat D.H., Tuch D.S., Hevelone N.D., et al. Age-related changes in prefrontal white matter measured by diffusion tensor imaging. Ann N Y Acad Sci 1064 (2005) 37-49
115. van Buchem M.A., Steens S.C., Vrooman H.A., et al. Global estimation of myelination in the developing brain on the basis of magnetization transfer imaging: a preliminary study. AJNR Am J Neuroradiol 22 (2001) 762-766
116. Engelbrecht V., Rassek M., Preiss S., et al. Age-dependent changes in magnetization transfer contrast of white matter in the pediatric brain. AJNR Am J Neuroradiol 19 (1998) 1923-1929
117. Silver N.C., Barker G.J., MacManus D.G., et al. Magnetisation transfer ratio of normal brain white matter: a normative database spanning four decades of life. J Neurol Neurosurg Psychiatry 62 (1997) 223-228
118. Armstrong C.L., Traipe E., Hunter J.V., et al. Age-related, regional, hemispheric, and medial-lateral differences in myelin integrity in vivo in the normal adult brain. AJNR Am J Neuroradiol 25 (2004) 977-984
119. Rovaris M., Iannucci G., Cercignani M., et al. Age-related changes in conventional, magnetization transfer, and diffusion-tensor MR imaging findings: study with whole-brain tissue histogram analysis. Radiology 227 (2003) 731-738
120. Mehta R.C., Pike G.B., and Enzmann D.R. Magnetization transfer MR of the normal adult brain. AJNR Am J Neuroradiol 16 (1995) 2085-2091
121. Vavasour I.M., Clark C.M., Li D.K., and Mackay A.L. Reproducibility and reliability of MR measurements in white matter: clinical implications. Neuroimage 32 (2006) 637-642
122. Vavasour I.M., Whittall K.P., MacKay A.L., et al. A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients. Magn Reson Med 40 (1998) 763-768
123. Cady E.B., Penrice J., Amess P.N., et al. Lactate, N-acetylaspartate, choline and creatine concentrations, and spin-spin relaxation in thalamic and occipito-parietal regions of developing human brain. Magn Reson Med 36 (1996) 878-886
124. Kreis R., Ernst T., and Ross B.D. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 30 (1993) 424-437
125. Barker P.B., Soher B.J., Blackband S.J., et al. Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference. NMR Biomed 6 (1993) 89-94
126. Brooks J.C., Roberts N., Kemp G.J., et al. A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb Cortex 11 (2001) 598-605
127. Schuff N., Ezekiel F., Gamst A.C., et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med 45 (2001) 899-907
128. Leary S.M., Brex P.A., MacManus D.G., et al. A (1)H magnetic resonance spectroscopy study of aging in parietal white matter: implications for trials in multiple sclerosis. Magn Reson Imaging 18 (2000) 455-459
129. Kreis R., Slotboom J., Hofmann L., and Boesch C. Integrated data acquisition and processing to determine metabolite contents, relaxation times, and macromolecule baseline in single examinations of individual subjects. Magn Reson Med 54 (2005) 761-768
130. Laule C., Vavasour I.M., Moore G.R.W., et al. Water content and myelin water fraction in multiple sclerosis: a T2 relaxation study. J Neurol 251 (2004) 284-293
131. Flynn S.W., Lang D.J., Mackay A.L., et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry 8 (2003) 811-820
132. Minty E., MacKay A., and Whittall K.P. Measurement of myelin water in human and bovine spinal cord. [abstract]. Int Soc Magn Reson Med Sci (2002) 940 Honolulu, Hawaii
133. Laule C., Vavasour I.M., Vavasour J.D., et al. Cervical cord abnormalities in primary progressive multiple sclerosis: atrophy and myelin water changes. Mult Scler 9 suppl 1 (2003) S63
134. Gomez-Anson B., MacManus D.G., Parker G.J., et al. In vivo 1H-magnetic resonance spectroscopy of the spinal cord in humans. Neuroradiology 42 (2000) 515-517
135. Kendi A.T., Tan F.U., Kendi M., et al. MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 46 (2004) 764-769
136. Marliani A.F., Clementi V., Albini-Riccioli L., et al. Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 Tesla. Magn Reson Med 57 (2007) 160-163
137. Inglese M., Rovaris M., Bianchi S., et al. Magnetic resonance imaging, magnetisation transfer imaging, and diffusion weighted imaging correlates of optic nerve, brain, and cervical cord damage in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry 70 (2001) 444-449
138. Rovaris M., Bozzali M., Rocca M.A., et al. An MR study of tissue damage in the cervical cord of patients with migraine. J Neurol Sci 183 (2001) 43-46
139. Inglese M., Salvi F., Iannucci G., et al. Magnetization transfer and diffusion tensor MR imaging of acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 23 (2002) 267-272
140. Hickman S.J., Hadjiprocopis A., Coulon O., et al. Cervical spinal cord MTR histogram analysis in multiple sclerosis using a 3D acquisition and a B-spline active surface segmentation technique. Magn Reson Imaging 22 (2004) 891-895
141. Renoux J., Facon D., Fillard P., et al. MR diffusion tensor imaging and fiber tracking in inflammatory diseases of the spinal cord. AJNR Am J Neuroradiol 27 (2006) 1947-1951
142. Hesseltine S.M., Law M., Babb J., et al. Diffusion tensor imaging in multiple sclerosis: assessment of regional differences in the axial plane within normal-appearing cervical spinal cord. AJNR Am J Neuroradiol 27 (2006) 1189-1193
143. Agosta F., Rocca M.A., Benedetti B., et al. MR imaging assessment of brain and cervical cord damage in patients with neuroborreliosis. AJNR Am J Neuroradiol 27 (2006) 892-894
144. Filley C. The behavioural neurology of white matter (2001), Oxford University Press, Oxford, NY
145. Keegan B.M., and Noseworthy J.H. Multiple sclerosis. Annu Rev Med 53 (2002) 285-302
146. Lin F., Yu C., Jiang T., et al. Diffusion tensor tractography-based group mapping of the pyramidal tract in relapsing-remitting multiple sclerosis patients. AJNR Am J Neuroradiol 28 (2007) 278-282
147. Larsson H.B., Thomsen C., Frederiksen J., et al. In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. Magn Reson Imaging 10 (1992) 7-12
148. Christiansen P., Gideon P., Thomsen C., et al. Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acta Neurol Scand 87 (1993) 195-199
149. Bammer R., Augustin M., Strasser-Fuchs S., et al. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med 44 (2000) 583-591
150. Castriota-Scanderbeg A., Sabatini U., Fasano F., et al. Diffusion of water in large demyelinating lesions: a follow-up study. Neuroradiology 44 (2002) 764-767
151. Clark C.A., Werring D.J., and Miller D.H. Diffusion imaging of the spinal cord in vivo: estimation of the principal diffusivities and application to multiple sclerosis. Magn Reson Med 43 (2000) 133-138
152. Agosta F., Benedetti B., Rocca M.A., et al. Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI. Neurology 64 (2005) 631-635
153. Campi A., Filippi M., Comi G., et al. Magnetisation transfer ratios of contrast-enhancing and nonenhancing lesions in multiple sclerosis. Neuroradiology 38 (1996) 115-119
154. Dousset V., Gayou A., Brochet B., and Caille J.M. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Neurology 51 (1998) 1150-1155
155. Silver N.C., Lai M., Symms M.R., et al. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology 51 (1998) 758-764
156. Rocca M.A., Mastronardo G., Rodegher M., et al. Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis. AJNR Am J Neuroradiol 20 (1999) 821-827
157. Cercignani M., Iannucci G., Rocca M.A., et al. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology 54 (2000) 1139-1144
158. Laule C., Vavasour I.M., Whittall K.P., et al. Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis. J Neurol 250 (2003) 924-931
159. Barkhof F., Bruck W., De Groot C.J., et al. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol 60 (2003) 1073-1081
160. Hiehle Jr. J.F., Grossman R.I., Ramer K.N., et al. Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. AJNR Am J Neuroradiol 16 (1995) 69-77
161. Filippi M., Rocca M.A., Martino G., et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 43 (1998) 809-814
162. Goodkin D.E., Rooney W.D., Sloan R., et al. A serial study of new MS lesions and the white matter from which they arise. Neurology 51 (1998) 1689-1697
163. Fazekas F., Ropele S., Enzinger C., et al. Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis. Mult Scler 8 (2002) 479-484
164. Levesque I., Sled J.G., Narayanan S., et al. The role of edema and demyelination in chronic T1 black holes: a quantitative magnetization transfer study. J Magn Reson Imaging 21 (2005) 103-110
165. Davies G.R., Tozer D.J., Cercignani M., et al. Estimation of the macromolecular proton fraction and bound pool T2 in multiple sclerosis. Mult Scler 10 (2004) 607-613
166. Wolinsky J.S., Narayana P.A., and Fenstermacher M.J. Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 40 (1990) 1764-1769
167. Koopmans R.A., Li D.K., Zhu G., et al. Magnetic resonance spectroscopy of multiple sclerosis: in-vivo detection of myelin breakdown products. Lancet 341 (1993) 631-632
168. Davie C.A., Hawkins C.P., Barker G.J., et al. Detection of myelin breakdown products by proton magnetic resonance spectroscopy. Lancet 341 (1993) 630-631
169. Narayana P.A., Doyle T.J., Lai D., and Wolinsky J.S. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 43 (1998) 56-71
170. Helms G., Stawiarz L., Kivisakk P., and Link H. Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions. Magn Reson Med 43 (2000) 102-110
171. Tartaglia M.C., Narayanan S., De Stefano N., et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 249 (2002) 1382-1390
172. Cercignani M., Bozzali M., Iannucci G., et al. Magnetisation transfer ratio and mean diffusivity of normal appearing white and gray matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 70 (2001) 311-317
173. rd Annual Scientific Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Warsaw, Poland
174. Henry R.G., Oh J., Nelson S.J., and Pelletier D. Directional diffusion in relapsing-remitting multiple sclerosis: a possible in vivo signature of Wallerian degeneration. J Magn Reson Imaging 18 (2003) 420-426
175. Vrenken H., Barkhof F., Uitdehaag B.M., et al. MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med 53 (2005) 256-266
176. Filippi M., Campi A., Dousset V., et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45 (1995) 478-482
177. Leary S.M., Silver N.C., Stevenson V.L., et al. Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis. Mult Scler 5 (1999) 313-316
178. Allen I.V., Glover G., and Anderson R. Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis (MS). Acta Neuropathol Suppl (Berl) 7 (1981) 176-178
179. Itoyama Y., Sternberger N.H., Webster H.D., et al. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions. Ann Neurol 7 (1980) 167-177
180. Tourtellotte W., and Parker J. Some spaces and barriers in postmortem multiple sclerosis. Prog Brain Res 29 (1968) 493-525
181. Alling C., Vanier M.T., and Svennerholm L. Lipid alterations in apparently normal white matter in multiple sclerosis. Brain Res 35 (1971) 325-336
182. Fewster M.E., Hirono H., and Mead J.F. Lipid composition of myelin in multiple sclerosis. J Neurol 213 (1976) 119-131
183. Suzuki K., Kamoshita S., Eto Y., et al. Myelin in multiple sclerosis. Composition of myelin from normal-appearing white matter. Arch Neurol 28 (1973) 293-297
184. Evangelou N., Esiri M.M., Smith S., et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 47 (2000) 391-395
185. Evangelou N., Konz D., Esiri M.M., et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 123 (2000) 1845-1849
186. Simon J.H., Kinkel R.P., Jacobs L., et al. A Wallerian degeneration pattern in patients at risk for MS. Neurology 54 (2000) 1155-1160
187. Fernando M.S., O'Brien J.T., Perry R.H., et al. Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol 30 (2004) 385-395
188. Sjobeck M., and Englund E. Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes. Neuropathol Appl Neurobiol 29 (2003) 159-169
189. Bartzokis G., Cummings J.L., Sultzer D., et al. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch Neurol 60 (2003) 393-398
190. Bartzokis G., Sultzer D., Lu P.H., et al. Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging 25 (2004) 843-851
191. Bartzokis G., Lu P.H., and Mintz J. Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease. J Alzheimers Dis 6 (2004) S53-S59
192. House M.J., St Pierre T.G., Foster J.K., et al. Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. AJNR Am J Neuroradiol 27 (2006) 430-439
193. Bozzali M., Falini A., Franceschi M., et al. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J Neurol Neurosurg Psychiatry 72 (2002) 742-746
194. Fellgiebel A., Muller M.J., Wille P., et al. Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment. Neurobiol Aging 26 (2005) 1193-1198
195. Medina D., DeToledo-Morrell L., Urresta F., et al. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging 27 (2006) 663-672
196. Naggara O., Oppenheim C., Rieu D., et al. Diffusion tensor imaging in early Alzheimer's disease. Psychiatry Res 146 (2006) 243-249
197. Choi S.J., Lim K.O., Monteiro I., and Reisberg B. Diffusion tensor imaging of frontal white matter microstructure in early Alzheimer's disease: a preliminary study. J Geriatr Psychiatry Neurol 18 (2005) 12-19
198. Back T., Mockel R., Hirsch J.G., et al. Combined MR measurements of magnetization transfer, tissue diffusion and proton spectroscopy. A feasibility study with neurological cases. Neurol Res 25 (2003) 292-300
199. van Es A.C., van der Flier W.M., Admiraal-Behloul F., et al. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 27 (2006) 1757-1762
200. Hanyu H., Asano T., Sakurai H., et al. Diffusion-weighted and magnetization transfer imaging of the corpus callosum in Alzheimer's disease. J Neurol Sci 167 (1999) 37-44
201. Kabani N.J., Sled J.G., and Chertkow H. Magnetization transfer ratio in mild cognitive impairment and dementia of Alzheimer's type. Neuroimage 15 (2002) 604-610
202. Bozzali M., Franceschi M., Falini A., et al. Quantification of tissue damage in AD using diffusion tensor and magnetization transfer MRI. Neurology 57 (2001) 1135-1137
203. van der Flier W.M., van den Heuvel D.M., Weverling-Rijnsburger A.W., et al. Magnetization transfer imaging in normal aging, mild cognitive impairment, and Alzheimer's disease. Ann Neurol 52 (2002) 62-67
204. Trapp B.D., Peterson J., Ransohoff R.M., et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338 (1998) 278-285
205. Kuhn M.J., Mikulis D.J., Ayoub D.M., et al. Wallerian degeneration after cerebral infarction: evaluation with sequential MR imaging. Radiology 172 (1989) 179-182
206. Lampert P.W., and Cressman M.R. Fine-structural changes of myelin sheaths after axonal degeneration in the spinal cord of rats. Am J Pathol 49 (1966) 1139-1155
207. Johnson A.C., Mc N.A., and Rossiter R.J. Chemistry of wallerian degeneration; a review of recent studies. Arch Neurol Psychiatry 64 (1950) 105-121
208. Englund E. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 9 (1998) 6-12
209. Yoshiura T., Mihara F., Koga H., et al. Mapping of subcortical white matter abnormality in Alzheimer's disease using diffusion-weighted magnetic resonance imaging. Acad Radiol 13 (2006) 1460-1464
210. Cleveland D.W., and Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2 (2001) 806-819
211. Buss A., Brook G.A., Kakulas B., et al. Gradual loss of myelin and formation of an astrocytic scar during Wallerian degeneration in the human spinal cord. Brain 127 (2004) 34-44
212. Ramon Y, Cajal S. Degeneration and regeneration of white matter. In: DeFilipe J, Jones E, eds. Cajal's Degeneration and Regeneration of the Nervous System. New York: Oxford University Press, 199:57-198.
213. Filbin M.T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 4 (2003) 703-713
214. Kerschensteiner M., Schwab M.E., Lichtman J.W., and Misgeld T. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat Med 11 (2005) 572-577
215. van der Knaap M.S., Breiter S.N., Naidu S., et al. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 213 (1999) 121-133
216. Barkovich A.J. Concepts of myelin and myelination in neuroradiology. AJNR Am J Neuroradiol 21 (2000) 1099-1109
217. Patay Z. Diffusion-weighted MR imaging in leukodystrophies. Eur Radiol 15 (2005) 2284-2303
218. Oguz K.K., Anlar B., Senbil N., and Cila A. Diffusion-weighted imaging findings in juvenile metachromatic leukodystrophy. Neuropediatrics 35 (2004) 279-282
219. Sener R.N. Diffusion magnetic resonance imaging patterns in metabolic and toxic brain disorders. Acta Radiol 45 (2004) 561-570
220. Farina L., Bizzi A., Finocchiaro G., et al. MR imaging and proton MR spectroscopy in adult Krabbe disease. AJNR Am J Neuroradiol 21 (2000) 1478-1482
221. Zarifi M.K., Tzika A.A., Astrakas L.G., et al. Magnetic resonance spectroscopy and magnetic resonance imaging findings in Krabbe's disease. J Child Neurol 16 (2001) 522-526
222. Brockmann K., Dechent P., Meins M., et al. Cerebral proton magnetic resonance spectroscopy in infantile Alexander disease. J Neurol 250 (2003) 300-306
223. Brockmann K., Dechent P., Wilken B., et al. Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease. Neurology 60 (2003) 819-825
224. Sener R.N. Metachromatic leukodystrophy. Diffusion MR imaging and proton MR spectroscopy. Acta Radiol 44 (2003) 440-443
225. Austin S.J., Connelly A., Gadian D.G., et al. Localized 1H NMR spectroscopy in Canavan's disease: a report of two cases. Magn Reson Med 19 (1991) 439-445
226. Wittsack H.J., Kugel H., Roth B., and Heindel W. Quantitative measurements with localized 1H MR spectroscopy in children with Canavan's disease. J Magn Reson Imaging 6 (1996) 889-893
227. Groenendaal F., Bianchi M.C., Battini R., et al. Proton magnetic resonance spectroscopy (1H-MRS) of the cerebrum in two young infants with Zellweger syndrome. Neuropediatrics 32 (2001) 23-27
228. Kingsley P.B., Shah T.C., and Woldenberg R. Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed 19 (2006) 435-462
229. Poser C.M., and Van Bogaert L. Neuro-pathologic observations in phenylketonuria. Brain 82 (1959) 1-9
230. Bechar M., Bornstein B., Elian M., and Sandbank U. Phenylketonuria presenting an intermittent progressive course. J Neurol Neurosurg Psychiatry 28 (1965) 165-170
231. Malamud N. Neuropathology of phenylketonuria. J Neuropathol Exp Neurol 25 (1966) 254-268
232. Bauman M.L., and Kemper T.L. Morphologic and histoanatomic observations of the brain in untreated human phenylketonuria. Acta Neuropathol (Berl) 58 (1982) 55-63
233. Shah S.N., Peterson N.A., and McKean C.M. Lipid composition of human cerebral white matter and myelin in phenylketonuria. J Neurochem 19 (1972) 2369-2376
234. Sirrs S.M., Laule C., Maedler B., et al. Normal appearing white matter in subjects with phenylketonuria: water content, myelin water fraction, and metabolite concentrations. Radiology 242 (2007) 236-243
235. Dezortova M., Hajek M., Tintera J., et al. MR in phenylketonuria-related brain lesions. Acta Radiologica 42 (2001) 459-466
236. Dezortova M., Hejcmanova L., and Hajek M. Decreasing choline signal-a marker of phenylketonuria?. MAGMA 4 (1996) 181-186
237. Johannik K., Van Hecke P., Francois B., et al. Localized brain proton NMR spectroscopy in young adult phenylketonuria patients. Magn Reson Med 31 (1994) 53-57
238. Kono K., Okano Y., Nakayama K., et al. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology 236 (2005) 630-636
239. Peng S.S., Tseng W.Y., Chien Y.H., et al. Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment. AJNR Am J Neuroradiol 25 (2004) 1569-1574
240. Leuzzi V., Tosetti M., Montanaro D., et al. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy ([1]H MRS) study. J Inherit Metab Dis 23 (2007) 23
241. Hakak Y., Walker J.R., Li C., et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 4746-4751
242. Uranova N., Orlovskaya D., Vikhreva O., et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull 55 (2001) 597-610
243. Tkachev D., Mimmack M.L., Huffaker S.J., et al. Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. Int J Neuropsychopharmacol (2007) 1-7
244. Bartzokis G., Nuechterlein K.H., Lu P.H., et al. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 53 (2003) 412-421
245. th Annual Meeting of the International Society of Magnetic Resonance in Medicine. Seattle
246. Fukuzako H. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. World J Biol Psychiatry 2 (2001) 70-82
247. Berger G.E., Wood S.J., Pantelis C., et al. Implications of lipid biology for the pathogenesis of schizophrenia. Aust N Z J Psychiatry 36 (2002) 355-366
248. Tanaka Y., Obata T., Sassa T., et al. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Psychiatry Clin Neurosci 60 (2006) 365-372
249. Sigmundsson T., Maier M., Toone B.K., et al. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 64 (2003) 63-71
250. Lim K.O., Hedehus M., Moseley M., et al. Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 56 (1999) 367-374
251. Agartz I., Andersson J.L., and Skare S. Abnormal brain white matter in schizophrenia: a diffusion tensor imaging study. Neuroreport 12 (2001) 2251-2254
252. Kubicki M., Park H., Westin C.F., et al. DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. Neuroimage 26 (2005) 1109-1118
253. Foong J., Maier M., Clark C.A., et al. Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 68 (2000) 242-244
254. Brambilla P., Cerini R., Gasparini A., et al. Investigation of corpus callosum in schizophrenia with diffusion imaging. Schizophr Res 79 (2005) 201-210
255. Kitamura H., Matsuzawa H., Shioiri T., et al. Diffusion tensor analysis in chronic schizophrenia. A preliminary study on a high-field (3.0T) system. Eur Arch Psychiatry Clin Neurosci 255 (2005) 313-318
256. Pfefferbaum A., Sullivan E.V., Hedehus M., et al. Brain gray and white matter transverse relaxation time in schizophrenia. Psychiatry Res 91 (1999) 93-100
257. Foong J., Maier M., Barker G.J., et al. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J Neurol Neurosurg Psychiatry 68 (2000) 70-74
258. Bagary M.S., Symms M.R., Barker G.J., et al. Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging. Arch Gen Psychiatry 60 (2003) 779-788
259. Bruck W., Kuhlmann T., and Stadelmann C. Remyelination in multiple sclerosis. J Neurol Sci 206 (2003) 181-185
260. Moore G.R.W. Neuropathology and pathophysiology of the multiple sclerosis lesion. In: Paty D., and Ebers G.C. (Eds). Multiple Sclerosis (1998), F.A. Davis, Philadelphia
261. Yu O., Steibel J., Mauss Y., et al. Remyelination assessment by MRI texture analysis in a cuprizone mouse model. Magn Reson Imaging 22 (2004) 1139-1144
262. Merkler D., Boretius S., Stadelmann C., et al. Multicontrast MRI of remyelination in the central nervous system. NMR Biomed 18 (2005) 395-403
263. Blakemore W.F. Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve. Nature 266 (1977) 68-69
264. Dunning M.D., Lakatos A., Loizou L., et al. Superparamagnetic iron oxide-labeled Schwann cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain functional properties after transplantation into the CNS. J Neurosci 24 (2004) 9799-9810
265. Bruck W., Bitsch A., Kolenda H., et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 42 (1997) 783-793
266. Degaonkar M.N., Khubchandhani M., Dhawan J.K., et al. Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC)-induced experimental demyelinating lesion model. NMR Biomed 15 (2002) 293-300
267. Vavasour I.M., MacKay A.L., Whittall K.P., et al. A serial magnetic resonance study of multiple sclerosis: T2 relaxation, T1 relaxation and magnetization transfer (1999) A360 Proceedings from the 51st Annual Meeting of the American Academy of Neurology, Toronto, Canada
268. Chen J.T., Collins D.L., Freedman M.S., et al. Local magnetization transfer ratio signal inhomogeneity is related to subsequent change in MTR in lesions and normal-appearing white-matter of multiple sclerosis patients. Neuroimage 25 (2005) 1272-1278
269. Stankiewicz J., Panter S.S., Neema M., Arora A., Batt C.E., and Bakshi R. Iron in chronic brain disorders: Imaging and neurotherapeutic implications. Neurotherapeutics 4 (2007) 371-386
270. Henkelman R.M., Stanisz G.J., and Graham S.J. Magnetization transfer in MRI: a review. NMR Biomed 14 (2001) 57-64
271. Suzuki S., Sakai O., and Jara H. Combined volumetric T1, T2 and secular-T2 quantitative MRI of the brain: age-related global changes (preliminary results). Magn Reson Imaging 24 (2006) 877-887
272. Ding X.Q., Kucinski T., Wittkugel O., et al. Normal brain maturation characterized with age-related T2 relaxation times: an attempt to develop a quantitative imaging measure for clinical use. Invest Radiol 39 (2004) 740-746
273. Moore G.R.W. MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS. J Neurol Sci 206 (2003) 175-179
274. Larsson H.B., Frederiksen J., Kjaer L., et al. In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med 7 (1988) 43-55
275. van Walderveen M.A., van Schijndel R.A., Pouwels P.J., et al. Multislice T1 relaxation time measurements in the brain using IR-EPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis. J Magn Reson Imaging 18 (2003) 656-664
276. Whittall K.P., MacKay A.L., Li D.K., et al. Normal-appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T(2). Magn Reson Med 47 (2002) 403-408
277. Sweet R.A., Panchalingam K., Pettegrew J.W., et al. Psychosis in Alzheimer disease: postmortem magnetic resonance spectroscopy evidence of excess neuronal and membrane phospholipid pathology. Neurobiol Aging 23 (2002) 547-553
278. Kantarci K., Petersen R.C., Boeve B.F., et al. 1H MR spectroscopy in common dementias. Neurology 63 (2004) 1393-1398
279. Catani M., Mecocci P., Tarducci R., et al. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. J Am Geriatr Soc 50 (2002) 1707-1710
280. Firbank M.J., Harrison R.M., and O'Brien J.T. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Dement Geriatr Cogn Disord 14 (2002) 64-76
281. Melberg A., Hallberg L., Kalimo H., and Raininko R. MR characteristics and neuropathology in adult-onset autosomal dominant leukodystrophy with autonomic symptoms. AJNR Am J Neuroradiol 27 (2006) 904-911
282. Young R.S., Osbakken M.D., Alger P.M., et al. Magnetic resonance imaging in leukodystrophies of childhood. Pediatr Neurol 1 (1985) 15-19
283. Ono J., Kodaka R., Imai K., et al. Evaluation of myelination by means of the T2 value on magnetic resonance imaging. Brain Dev 15 (1993) 433-438
284. Spaniel F., Herynek V., Hajek T., et al. Magnetic resonance relaxometry in monozygotic twins discordant and concordant for schizophrenia. Eur Psychiatry 20 (2005) 41-44
285. Andreasen N.C., Ehrhardt J.C., Swayze II V.W., et al. T1 and T2 relaxation times in schizophrenia as measured with magnetic resonance imaging. Schizophr Res 5 (1991) 223-232